These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 9028957

  • 21. Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis.
    Pensati L, Costanzo A, Ianni A, Accapezzato D, Iorio R, Natoli G, Nisini R, Almerighi C, Balsano C, Vajro P, Vegnente A, Levrero M.
    Gastroenterology; 1997 Oct; 113(4):1384-9. PubMed ID: 9322534
    [Abstract] [Full Text] [Related]

  • 22. Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome.
    Choi Y, Ramnath VR, Eaton AS, Chen A, Simon-Stoos KL, Kleiner DE, Erikson J, Puck JM.
    Clin Immunol; 1999 Oct; 93(1):34-45. PubMed ID: 10497009
    [Abstract] [Full Text] [Related]

  • 23. Cytomegalovirus infection in infants with autoimmune lymphoproliferative syndrome (ALPS).
    Arkwright PD, Rieux-Laucat F, Le Deist F, Stevens RF, Angus B, Cant AJ.
    Clin Exp Immunol; 2000 Aug; 121(2):353-7. PubMed ID: 10931153
    [Abstract] [Full Text] [Related]

  • 24. Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.
    Cerutti E, Campagnoli MF, Ferretti M, Garelli E, Crescenzio N, Rosolen A, Chiocchetti A, Lenardo MJ, Ramenghi U, Dianzani U.
    BMC Immunol; 2007 Nov 13; 8():28. PubMed ID: 17999750
    [Abstract] [Full Text] [Related]

  • 25. Autoimmune lymphoproliferative syndrome.
    Sneller MC, Dale JK, Straus SE.
    Curr Opin Rheumatol; 2003 Jul 13; 15(4):417-21. PubMed ID: 12819469
    [Abstract] [Full Text] [Related]

  • 26. Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
    Maric I, Pittaluga S, Dale JK, Niemela JE, Delsol G, Diment J, Rosai J, Raffeld M, Puck JM, Straus SE, Jaffe ES.
    Am J Surg Pathol; 2005 Jul 13; 29(7):903-11. PubMed ID: 15958855
    [Abstract] [Full Text] [Related]

  • 27. A new disorder of lymphocyte apoptosis: combination of autoimmunity, infectious lymphadenopathy, double negative T cells, and impaired activation-induced cell death.
    Hundt M, Posovszky C, Schmidt RE.
    Immunobiology; 2002 Dec 13; 206(5):514-8. PubMed ID: 12607726
    [Abstract] [Full Text] [Related]

  • 28. Perforin-dependent apoptosis functionally compensates Fas deficiency in activation-induced cell death of human T lymphocytes.
    Mateo V, Ménager M, de Saint-Basile G, Stolzenberg MC, Roquelaure B, André N, Florkin B, le Deist F, Picard C, Fischer A, Rieux-Laucat F.
    Blood; 2007 Dec 15; 110(13):4285-92. PubMed ID: 17724145
    [Abstract] [Full Text] [Related]

  • 29. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS).
    Teachey DT, Manno CS, Axsom KM, Andrews T, Choi JK, Greenbaum BH, McMann JM, Sullivan KE, Travis SF, Grupp SA.
    Blood; 2005 Mar 15; 105(6):2443-8. PubMed ID: 15542578
    [Abstract] [Full Text] [Related]

  • 30. Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
    Bi LL, Pan G, Atkinson TP, Zheng L, Dale JK, Makris C, Reddy V, McDonald JM, Siegel RM, Puck JM, Lenardo MJ, Straus SE.
    BMC Med Genet; 2007 Jul 02; 8():41. PubMed ID: 17605793
    [Abstract] [Full Text] [Related]

  • 31. TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
    Bleesing JJ, Brown MR, Dale JK, Straus SE, Lenardo MJ, Puck JM, Atkinson TP, Fleisher TA.
    Clin Immunol; 2001 Sep 02; 100(3):314-24. PubMed ID: 11513545
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency.
    Rensing-Ehl A, Völkl S, Speckmann C, Lorenz MR, Ritter J, Janda A, Abinun M, Pircher H, Bengsch B, Thimme R, Fuchs I, Ammann S, Allgäuer A, Kentouche K, Cant A, Hambleton S, Bettoni da Cunha C, Huetker S, Kühnle I, Pekrun A, Seidel MG, Hummel M, Mackensen A, Schwarz K, Ehl S.
    Blood; 2014 Aug 07; 124(6):851-60. PubMed ID: 24894771
    [Abstract] [Full Text] [Related]

  • 34. Deficiency of the Fas apoptosis pathway without Fas gene mutations is a familial trait predisposing to development of autoimmune diseases and cancer.
    Ramenghi U, Bonissoni S, Migliaretti G, DeFranco S, Bottarel F, Gambaruto C, DiFranco D, Priori R, Conti F, Dianzani I, Valesini G, Merletti F, Dianzani U.
    Blood; 2000 May 15; 95(10):3176-82. PubMed ID: 10807785
    [Abstract] [Full Text] [Related]

  • 35. Aberrant T-cell antigen receptor-mediated responses in autoimmune lymphoproliferative syndrome.
    Goldman FD, Vibhakar R, Puck JM, Straus SE, Ballas ZK, Hollenback C, Loew T, Thompson A, Song K, Cook RT.
    Clin Immunol; 2002 Jul 15; 104(1):31-9. PubMed ID: 12139945
    [Abstract] [Full Text] [Related]

  • 36. The autoimmune lymphoproliferative syndrome: an experiment of nature involving lymphocyte apoptosis.
    Fleisher TA.
    Immunol Res; 2008 Jul 15; 40(1):87-92. PubMed ID: 18193364
    [Abstract] [Full Text] [Related]

  • 37. Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
    Martin DA, Zheng L, Siegel RM, Huang B, Fisher GH, Wang J, Jackson CE, Puck JM, Dale J, Straus SE, Peter ME, Krammer PH, Fesik S, Lenardo MJ.
    Proc Natl Acad Sci U S A; 1999 Apr 13; 96(8):4552-7. PubMed ID: 10200300
    [Abstract] [Full Text] [Related]

  • 38. [Autoimmune lymphoproliferative syndrome: molecular diagnosis in two families].
    Cambronero R, Cámara C, López-Granados E, Ferreira A, Fontán G, García Rodríguez MC.
    Med Clin (Barc); 2003 May 03; 120(16):622-5. PubMed ID: 12732128
    [Abstract] [Full Text] [Related]

  • 39. Defective apoptosis due to a point mutation in the death domain of CD95 associated with autoimmune lymphoproliferative syndrome, T-cell lymphoma, and Hodgkin's disease.
    Peters AM, Kohfink B, Martin H, Griesinger F, Wörmann B, Gahr M, Roesler J.
    Exp Hematol; 1999 May 03; 27(5):868-74. PubMed ID: 10340403
    [Abstract] [Full Text] [Related]

  • 40. Development of lymphoma in Autoimmune Lymphoproliferative Syndrome (ALPS) and its relationship to Fas gene mutations.
    Poppema S, Maggio E, van den Berg A.
    Leuk Lymphoma; 2004 Mar 03; 45(3):423-31. PubMed ID: 15160902
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.